Prazosin for Post-Concussive Headaches
Prazosin for the Prophylaxis of Chronic Post-Traumatic Headaches in OEF/OIF/OND Service Members and Veterans With Mild TBI
Sponsor: Madigan Army Medical Center
A PHASE4 clinical study on Post-Traumatic Headache, this trial is completed. The trial is conducted by Madigan Army Medical Center and has accumulated 13 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Aug 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jul 2024 — Aug 2024 [monthly]
Completed PHASE4
-
Apr 2024 — Jul 2024 [monthly]
Completed PHASE4
Status: Active Not Recruiting → Completed
-
Jul 2023 — Apr 2024 [monthly]
Active Not Recruiting PHASE4
Status: Recruiting → Active Not Recruiting
▶ Show 8 earlier versions
-
Sep 2022 — Jul 2023 [monthly]
Recruiting PHASE4
-
Sep 2021 — Sep 2022 [monthly]
Recruiting PHASE4
-
Jan 2021 — Sep 2021 [monthly]
Recruiting PHASE4
-
May 2020 — Jan 2021 [monthly]
Recruiting PHASE4
-
Feb 2019 — May 2020 [monthly]
Recruiting PHASE4
-
Jun 2018 — Feb 2019 [monthly]
Recruiting PHASE4
-
Feb 2017 — Jun 2018 [monthly]
Recruiting PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE4
First recorded
Nov 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Madigan Army Medical Center
- Seattle Institute for Biomedical and Clinical Research
- VA Puget Sound Health Care System
For direct contact, visit the study record on ClinicalTrials.gov .